[Clinical efficacy and safety of levocarbastine++ in the therapy in children suffering from seasonal allergic rhinitis and conjunctivitis who are less than 12 year of age].
Levocabastine is an antihistaminic agent for topical application. It is without not advisable general side-effects and since many years is widely used for the treatment of pollinosis in adults and children more than 12 years of age. The group of 32 children aged from 5 to 11 years suffering from seasonal allergic rhinitis and conjunctivitis were treated by means of levocabastine applied topically by 20 days during the period of natural exposition to grass pollen. The clinical efficacy and tolerability including potential side-effects, were evaluated on the basis of clinical-laryngological investigations, visual analogs scales and diary cards filed in by parents of examined children. Levocabastine has been demonstrated to have rapid onset of action in children with SAR and the topical application of the drug does not irritate the mucosa of conjunctivas and nasal cavities.
Kurzawa
R
R
Instytutu Gruźlicy i Chorób Płuc Oddział w Rabce.
Kossek
M
M
Doniec
Z
Z
Mazurek
H
H
Urbanek
E
E
Sak-Kopytyńska
I
I
Radliński
J
J
Bukowczan
Z
Z
D002648:Child; D002675:Child, Preschool; D003233:Conjunctivitis, Allergic / Q000188:drug therapy*; D006634:Histamine H1 Antagonists / Q000627:therapeutic use*; D006801:Humans; D010880:Piperidines / Q000627:therapeutic use*; D006255:Rhinitis, Allergic, Seasonal / Q000188:drug therapy*
D006634:Histamine H1 Antagonists; D010880:Piperidines; C047340:levocabastine
Ocena skuteczności klinicznej i bezpieczeństwa lewokabastyny w leczeniu pyłkowicy u dzieci ponizej 12. roku zycia.